Toll-like receptor 3 expressed by melanoma cells as a target for therapy?

@article{Salaun2007TolllikeR3,
  title={Toll-like receptor 3 expressed by melanoma cells as a target for therapy?},
  author={Bruno Salaun and Serge J. Lebecque and Sampsa Matikainen and Donata Rimoldi and Pedro Romero},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2007},
  volume={13 15 Pt 1},
  pages={4565-74}
}
PURPOSE The immunomodulatory properties of Toll-like receptors (TLR) agonists have inspired their use as experimental adjuvants for vaccination of cancer patients. However, it is now well recognized that TLR expression is not restricted to immune cells but can also be found in many cell types, including those giving rise to tumors. It is therefore mandatory to explore the potential effects of TLR triggering directly on tumor cells. EXPERIMENTAL DESIGN In the present work, we have investigated… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 92 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 56 references

Toll - like receptor 3 associates with cSrc tyrosine kinase on endosomes to initiate antiviral signaling

  • NguyenTT Johnsen IB, M Ringdal
  • EMBO J
  • 2006

TriggeringTLR signaling in vaccination

  • D vanDuin, ShawAC Medzhitov R
  • Trends Immunol
  • 2006

Similar Papers

Loading similar papers…